Page 506 - IJB-9-5
P. 506

International Journal of Bioprinting                             Implantation of composites for cartilage repair




























            Figure 1. Fabrication of MEW-NorHA composites. (A) Overview of the melt electrowriting (MEW) of polycaprolactone (PCL) microfibers to form
            MEW scaffolds. (B) (Left) Schematic of MEW scaffolds formed via deposition of overlaying, perpendicular MEW fibers with 400 μm interfiber spacing,
            and (right) representative micrograph of the MEW scaffold (cyan). (C) (Left) Schematic of the MEW-NorHA composites used to evaluate adult porcine
            mesenchymal  stromal  cells  (pMSCs)  sourced  from  three  porcine  donors  and  (right)  representative  images  of  MEW-NorHA  composites  containing
            encapsulated pMSCs during culture.
            crosslinking chemistry used to form NorHA hydrogels and   cm , data not shown). In addition, pMSCs isolated from
                                                                 2
            MEW-NorHA composites is hydrolytically stable, such   Donor 3 and encapsulated in composites led to neotissue
            that long-term culture may be performed in vitro without   with significantly higher sulfated glycosaminoglycan
            loss of construct stability .                      contents than composites produced from Donor 1 or 2
                                [37]
                                                               (Figure 3). Composites containing cells sourced from
               Since donor variability is known to influence
            human MSC properties, such as proliferation and    Donor 3 also possessed higher average collagen content
                                                               after culture (25.1 ± 9.5 μg/construct) compared to
            differentiation , pMSCs from three prospective porcine   composites containing cells sourced from Donor 1 (21.1 ±
                       [38]
            donors were screened to identify a cell source with the   4.0 μg/construct) or Donor 2 (16.9 ± 3.3 μg/construct).
            requisite chondrogenic potential to form neocartilage
            when cultured in chondrogenic media for 28 days       Evaluation of these composites via histology and
            (Figure 3). Given the age of the encapsulated adult pMSCs,   immunohistochemistry also demonstrated that composites
            it was expected that the mechanical properties and relative   containing cells from Donors 1 and 3 stained more intensely
            amounts of cartilaginous ECM components observed in   for sGAG  and type  I collagen (COL I)  than composites
            these composites would be inferior to those previously   containing cells from Donor 2 (Figure 4). However, the
            reported in composites containing juvenile bovine MSCs;   morphology of the encapsulated pMSCs, the relative
            however, increases in the compressive moduli of pMSC-  distribution and organization of ECM, and the overall
            laden composites were still observed over 28 days when   staining intensity were qualitatively comparable across all
            compared to acellular composite controls (~100 kPa) .  donors (Figure 4). In addition, relatively intense type II
                                                      [21]
                                                               collagen (COL II) staining was observed in the pericellular
               Minimal differences were observed across the donors
            with respect to the compressive moduli (~160  kPa) of   space of encapsulated cells across all the samples, consistent
                                                               with previously reported staining in NorHA hydrogels
            cultured composites (Figure 3). However, the DNA content   containing bovine MSCs . Based on these results, Donor
                                                                                   [23]
            of composites cultured with pMSCs from Donor 3 was   3 was selected as  the primary allogeneic cell source  for
            significantly higher than that of composites containing   all the cell-laden composites fabricated and cultured
            pMSCs from Donor 2 despite all the cell-laden composites   for implantation  in vivo  to maximize the chondrogenic
            being fabricated with the same density of encapsulated   potential of the precultured composite implants.
            cells. This suggests that cells from Donor 3 may have
            had an innately higher proliferative capacity. This data is   3.2. Construct implantation
            qualitatively corroborated by the observation of faster   After screening porcine donors, we next sought to evaluate
            proliferation for Donor 3 cells compared to other donors (all   the fixation of MEW-NorHA composites in vivo using a
            plated on tissue culture plastic at a density of 6.67 × 10  cells/  porcine model of full-thickness cartilage defects (Figure 5A)
                                                     3
            Volume 9 Issue 5 (2023)                        498                         https://doi.org/10.18063/ijb.775
   501   502   503   504   505   506   507   508   509   510   511